We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $824M
1-Year Est. Return 78.19%
This Fund
S&P 500
This Quarter Est. Return
+14.81%
1 Year Est. Return
+78.19%
3 Year Est. Return
+156.18%
5 Year Est. Return
+168.38%
10 Year Est. Return
+388.18%
AUM
$410M
AUM Growth
+$32.8M
Cap. Flow
-$16.9M
Cap. Flow %
-4.11%
Top 10 Hldgs %
40.83%
Holding
122
New
21
Increased
22
Reduced
44
Closed
13
Avg Time Held
13.2 quarters
Top 10 Avg Time Held
11.4 quarters
Top 20 Avg Time Held
11.8 quarters

Top Buys

Rank Stock Value
1
TMP icon
Tompkins Financial
TMP
+$4.16M
2
AGX icon
Argan
AGX
+$3.97M
3
MDU icon
MDU Resources
MDU
+$3.14M
4
AGR icon
Avangrid, Inc.
AGR
+$2.94M
5
OGE icon
OGE Energy
OGE
+$2.8M

Top Sells

Rank Stock Value
1
EMR icon
Emerson Electric
EMR
+$8.58M
2
BNS icon
Scotiabank
BNS
+$5.36M
3
GLW icon
Corning
GLW
+$5.06M
4
GVA icon
Granite Construction
GVA
+$5.01M
5
XOM icon
ExxonMobil
XOM
+$2.84M

Sector Composition

Rank Sector Weight
1 Healthcare 36.18%
2 Technology 23.21%
3 Industrials 21.08%
4 Utilities 8.25%
5 Communication Services 4.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
EMR icon
1
Emerson Electric
EMR
$91.2B
$26.9M 6.56%
433,545
-151,074
-26% -$8.58M
2013 Q2
28 quarters
BMY icon
2
Bristol-Myers Squibb
BMY
$116B
$24.1M 5.88%
409,790
-693
-0.2% -$41.5K
2013 Q2
28 quarters
PFE icon
3
Pfizer
PFE
$162B
$17.6M 4.3%
567,430
+1,887
+0.3% +$64.1K
2013 Q2
28 quarters
GLW icon
4
Corning
GLW
$128B
$17.2M 4.19%
662,578
-223,385
-25% -$5.06M
2013 Q2
28 quarters
GSK icon
5
GSK
GSK
$92.7B
$16.9M 4.13%
331,920
-9,220
-3% -$473K
2013 Q2
28 quarters
INTC icon
6
Intel
INTC
$543B
$14.4M 3.51%
240,452
-6,166
-3% -$369K
2013 Q2
28 quarters
NVS icon
7
Novartis
NVS
$271B
$13.3M 3.25%
152,485
-350
-0.2% -$30.2K
2013 Q2
28 quarters
JNJ icon
8
Johnson & Johnson
JNJ
$599B
$13M 3.17%
92,416
-268
-0.3% -$39.1K
2013 Q2
28 quarters
MMM icon
9
3M
MMM
$83.9B
$12.3M 3.01%
94,482
-2,212
-2% -$279K
2013 Q2
28 quarters
OGE icon
10
OGE Energy
OGE
$9.75B
$11.6M 2.84%
382,808
+90,550
+31% +$2.8M
2013 Q2
28 quarters
LGTY
11
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
$11.6M 2.82%
733,340
-5,233
-0.7% -$88K
2013 Q2
28 quarters
MDU icon
12
MDU Resources
MDU
$3.92B
$11.5M 2.82%
1,367,998
+377,415
+38% +$3.14M
2013 Q2
28 quarters
AGX icon
13
Argan
AGX
$5.44B
$11.2M 2.74%
237,149
+103,874
+78% +$3.97M
2018 Q2
8 quarters
IBM icon
14
IBM
IBM
$217B
$10.9M 2.67%
94,642
+19,952
+27% +$2.32M
2013 Q2
28 quarters
BCE icon
15
BCE
BCE
$18.2B
$10.8M 2.64%
258,815
+11,988
+5% +$493K
2013 Q2
28 quarters
XRAY icon
16
Dentsply Sirona
XRAY
$1.7B
$9.97M 2.43%
226,350
+15,350
+7% +$649K
2018 Q3
7 quarters
MSFT icon
17
Microsoft
MSFT
$4.04T
$8.91M 2.17%
43,785
+303
+0.7% +$55K
2013 Q2
28 quarters
TMO icon
18
Thermo Fisher Scientific
TMO
$245B
$8.35M 2.04%
23,054
-150
-0.6% -$50.3K
2013 Q2
28 quarters
LNN icon
19
Lindsay Corp
LNN
$1.17B
$8.03M 1.96%
87,057
-200
-0.2% -$18.3K
2013 Q2
28 quarters
ABT icon
20
Abbott
ABT
$178B
$7.85M 1.92%
85,879
-32
-0% -$2.89K
2013 Q2
28 quarters
TEL icon
21
TE Connectivity
TEL
$62.5B
$6.58M 1.61%
80,700
+4,700
+6% +$354K
2013 Q2
28 quarters
MRK icon
22
Merck
MRK
$350B
$6.3M 1.54%
85,453
-401
-0.5% -$30.2K
2013 Q2
28 quarters
ADM icon
23
Archer Daniels Midland
ADM
$40.1B
$6.19M 1.51%
155,250
-100
-0.1% -$3.74K
2018 Q4
6 quarters
LITE icon
24
Lumentum
LITE
$89.5B
$5.75M 1.4%
70,678
-1,700
-2% -$130K
2019 Q1
5 quarters
HON icon
25
Honeywell
HON
$65.7B
$5.7M 1.39%
41,804
-637
-2% -$84.3K
2013 Q2
28 quarters
1
2 3 4 5

Similar funds

SWIG
Strategic Wealth Investment Group Louisville, Kentucky $825M AUM 11.63% 1-Year Est. Return
RP
Rice Partnership Honolulu, Hawaii $824M AUM 40.45% 1-Year Est. Return
WRPWM
Werba Rubin Papier Wealth Management San Jose, California $824M AUM 24.76% 1-Year Est. Return
IA
Intellus Advisors Naples, Florida $823M AUM 36.99% 1-Year Est. Return
PCM
Parsifal Capital Management Greenwich, Connecticut $826M AUM 47.87% 1-Year Est. Return
MGAM
McGowan Group Asset Management Dallas, Texas $823M AUM 27.48% 1-Year Est. Return
HVIA
Hudson Valley Investment Advisors Goshen, New York $823M AUM 31.4% 1-Year Est. Return
MWP
Meridian Wealth Partners Exton, Pennsylvania $826M AUM 21.35% 1-Year Est. Return

John G. Ullman & Associates's Q2 2020 Portfolio in Review

As of Q2 2020, John G. Ullman & Associates held 122 positions worth $410M, up 8.7% from $377M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

John G. Ullman & Associates withdrew a net $16.9M in Q2 2020, closing 13 positions and reducing 44 holdings. Its most notable exit was Scotiabank, an estimated $5.36M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 35% a quarter earlier, followed by Technology and Industrials.

Against the trend, John G. Ullman & Associates opened a new position in Tompkins Financial worth $4.13M.

  • John G. Ullman & Associates's largest Q2 2020 buy was Tompkins Financial: 63,735 shares worth $4.13M.
  • John G. Ullman & Associates added most to Argan in Q2 2020, an estimated $3.97M increase.
  • John G. Ullman & Associates's biggest Q2 2020 reduction was Emerson Electric, cutting an estimated $8.58M.
  • John G. Ullman & Associates fully exited Scotiabank in Q2 2020, selling an estimated $5.36M.
  • John G. Ullman & Associates's ten largest holdings make up 41% of its $410M portfolio in Q2 2020.
  • John G. Ullman & Associates opened 21 new positions and closed 13 in Q2 2020.
  • John G. Ullman & Associates's portfolio value rose 8.7% quarter-over-quarter to $410M.

Based on John G. Ullman & Associates's 13F filing for Q2 2020, filed 29 Jul 2020.